CVS HEALTH Corp
CVSNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for CVS. That does not mean none is planned.
Get an email about CVS's next catalysts
Track CVS HEALTH (CVS) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
CVS Health Corporation is an American multinational healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's second largest healthcare company, behind UnitedHealth Group. In 2023, the company was ranked 64th in the Forbes Global 2000. CVS started in Lowell, Massachusetts by brothers Stanley and Sidney Goldstein and their partner Ralph Hoagland. The name stood for Consumer Value Stores.
WebsiteNo drugs found in this phase.
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
When is CVS HEALTH Corp's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for CVS HEALTH Corp (CVS) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CVS biotech catalysts?→
Add CVS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CVS HEALTH Corp's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.